31842924|t|Region-specific blood-brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer's disease.
31842924|a|BACKGROUND: Research into amisulpride use in Alzheimer's disease (AD) implicates blood-brain barrier (BBB) dysfunction in antipsychotic sensitivity. Research into BBB transporters has been mainly directed towards the ABC superfamily, however, solute carrier (SLC) function in AD has not been widely studied. This study tests the hypothesis that transporters for organic cations contribute to the BBB delivery of the antipsychotics (amisulpride and haloperidol) and is disrupted in AD. METHODS: The accumulation of [3H]amisulpride (3.7-7.7 nM) and [3H]haloperidol (10 nM) in human (hCMEC/D3) and mouse (bEnd.3) brain endothelial cell lines was explored. Computational approaches examined molecular level interactions of both drugs with the SLC transporters [organic cation transporter 1 (OCT1), plasma membrane monoamine transporter (PMAT) and multi-drug and toxic compound extrusion proteins (MATE1)] and amisulpride with the ABC transporter (P-glycoprotein). The distribution of [3H]amisulpride in wildtype and 3xtransgenic AD mice was examined using in situ brain perfusion experiments. Western blots determined transporter expression in mouse and human brain capillaries . RESULTS: In vitro BBB and in silico transporter studies indicated that [3H]amisulpride and [3H]haloperidol were transported by the influx transporter, OCT1, and efflux transporters MATE1 and PMAT. Amisulpride did not have a strong interaction with OCTN1, OCTN2, P-gp, BCRP or MRP and could not be described as a substrate for these transporters. Amisulpride brain uptake was increased in AD mice compared to wildtype mice, but vascular space was unaffected. There were no measurable changes in the expression of MATE1, MATE2, PMAT OCT1, OCT2, OCT3, OCTN1, OCTN2 and P-gp in capillaries isolated from whole brain homogenates from the AD mice compared to wildtype mice. Although, PMAT and MATE1 expression was reduced in capillaries obtained from specific human brain regions (i.e. putamen and caudate) from AD cases (Braak stage V-VI) compared to age matched controls (Braak stage 0-II). CONCLUSIONS: Together our research indicates that the increased sensitivity of individuals with Alzheimer's to amisulpride is related to previously unreported changes in function and expression of SLC transporters at the BBB (in particular PMAT and MATE1). Dose adjustments may be required for drugs that are substrates of these transporters when prescribing for individuals with AD.
31842924	90	101	amisulpride	Chemical	MESH:D000077582
31842924	105	124	Alzheimer's disease	Disease	MESH:D000544
31842924	152	163	amisulpride	Chemical	MESH:D000077582
31842924	171	190	Alzheimer's disease	Disease	MESH:D000544
31842924	192	194	AD	Disease	MESH:D000544
31842924	402	404	AD	Disease	MESH:D000544
31842924	558	569	amisulpride	Chemical	MESH:D000077582
31842924	574	585	haloperidol	Chemical	MESH:D006220
31842924	607	609	AD	Disease	MESH:D000544
31842924	640	655	[3H]amisulpride	Chemical	-
31842924	673	688	[3H]haloperidol	Chemical	-
31842924	700	705	human	Species	9606
31842924	707	715	hCMEC/D3	CellLine	CVCL:U985
31842924	721	726	mouse	Species	10090
31842924	728	734	bEnd.3	CellLine	CVCL:0170
31842924	883	911	organic cation transporter 1	Gene	6580
31842924	913	917	OCT1	Gene	6580
31842924	920	957	plasma membrane monoamine transporter	Gene	243328
31842924	959	963	PMAT	Gene	243328
31842924	1019	1024	MATE1	Gene	67473
31842924	1031	1042	amisulpride	Chemical	MESH:D000077582
31842924	1106	1121	[3H]amisulpride	Chemical	-
31842924	1151	1153	AD	Disease	MESH:D000544
31842924	1154	1158	mice	Species	10090
31842924	1266	1271	mouse	Species	10090
31842924	1276	1281	human	Species	9606
31842924	1373	1388	[3H]amisulpride	Chemical	-
31842924	1393	1408	[3H]haloperidol	Chemical	-
31842924	1453	1457	OCT1	Gene	6580
31842924	1483	1488	MATE1	Gene	67473
31842924	1493	1497	PMAT	Gene	243328
31842924	1499	1510	Amisulpride	Chemical	MESH:D000077582
31842924	1550	1555	OCTN1	Gene	30805
31842924	1557	1562	OCTN2	Gene	20520
31842924	1564	1568	P-gp	Gene	67078
31842924	1570	1574	BCRP	Gene	26357
31842924	1578	1581	MRP	Gene	17250
31842924	1648	1659	Amisulpride	Chemical	MESH:D000077582
31842924	1690	1692	AD	Disease	MESH:D000544
31842924	1693	1697	mice	Species	10090
31842924	1719	1723	mice	Species	10090
31842924	1814	1819	MATE1	Gene	67473
31842924	1821	1826	MATE2	Gene	380701
31842924	1828	1832	PMAT	Gene	243328
31842924	1833	1837	OCT1	Gene	20517
31842924	1839	1843	OCT2	Gene	20518
31842924	1845	1849	OCT3	Gene	20519
31842924	1851	1856	OCTN1	Gene	30805
31842924	1858	1863	OCTN2	Gene	20520
31842924	1868	1872	P-gp	Gene	67078
31842924	1935	1937	AD	Disease	MESH:D000544
31842924	1938	1942	mice	Species	10090
31842924	1964	1968	mice	Species	10090
31842924	1980	1984	PMAT	Gene	243328
31842924	1989	1994	MATE1	Gene	67473
31842924	2056	2061	human	Species	9606
31842924	2108	2110	AD	Disease	MESH:D000544
31842924	2285	2296	Alzheimer's	Disease	MESH:D000544
31842924	2300	2311	amisulpride	Chemical	MESH:D000077582
31842924	2429	2433	PMAT	Gene	243328
31842924	2438	2443	MATE1	Gene	67473
31842924	2569	2571	AD	Disease	MESH:D000544
31842924	Association	MESH:D000077582	MESH:D000544

